We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Korean Scientist Faked Stem Cell Research

By Biotechdaily staff writers
Posted on 09 Jan 2006
Following an investigation, a panel at Seoul National University (Korea) has announced that Hwang Woo Suk, its leading scientist, falsified the results of his experiments to clone embryos and extract stem cells from them to match patients.

In an article in Science in June 2005, Dr. More...
Hwang claimed to have cloned human embryos by transferring the nucleus of an adult cell into an egg and then to have extracted stem cells from that egg that genetically matched patients, who would then be able to produce regenerated tissues that could treat their diseases.

Seoul University's Dean of Research Affairs, Dr. Roe Jung Hye, has reported that Dr. Hwang's team does not have scientific data to prove it has produced such stem cells. Furthermore, following extensive DNA testing, the investigative panel found that none of the stem cells created by Dr. Hwang were produced by cloning but were from fertilized eggs and were not designed specifically for patients. Now, the panel is also investigating a 2004 study by Dr. Hwang as well as his claim to have produced the first cloned dog. The panel is to announce it findings in mid-January, according to Dr. Roe.

In the meantime, Dr. Hwang has claimed that the authentic stem cells he developed were stolen from his lab, replaced by samples from MizMedi Hospital in Seoul, which participated in his research. However, he has resigned from the university and has apologized for the falsifications in his paper.

The episode has dashed the hopes of scientists worldwide who thought Dr. Hwang's work would be able to advance the technology for therapeutic cloning.



New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Thyroid Test
Anti-Thyroid EIA Test
New
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.